- HealthQ Special: Caregiving in the Sandwich Generation
- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Didn’t Tell the FDA.
- New Disease Threats Follow Trump Administration’s Health Program Cuts
- Author Health expands mental health, dementia care services
- PDS Health opened 5 de novo offices in June
- Heartland Dental added 6 de novo offices in June
- Hospital groups push back on tax-exempt hospital bill: 9 things to know
- What other health systems could borrow from HCA, per an incoming hospital CEO
- CMS seeks new powers to remove ‘problematic’ Medicare providers — 8 things to know
- Why Northwell didn’t rush the Nuvance rebrand
- VCU Health taps president for planned hospital
- VA undersecretary resigns after less than 1 year
- What happens when ‘clinician in the loop’ makes AI worse?
- Children’s Hospital Colorado launches new brand campaign
- Why Physicians Belong in the Mid-Revenue Cycle
- Vanderbilt surgeons 1st in US to perform surgery with imaging tech
- AANA withdraws ‘nurse anesthesiologist’ trademark applications after ASA opposition
- 10 notes on dental M&A in 2026
- Dental implant manufacturer hit with ransomware attack
- Cedars-Sinai taps new head of ENT surgery
- 15 new ASCs in June
- The contract red flags behind Erlanger’s $21M Stark law case
- Premier Anesthesia, Hughston Clinic partner to expand orthopedic surgery access
- Physician gets $6.8M verdict in lawsuit against former employer
- Specialized Dental Partners adds Kentucky periodontics practice
- Seva Dental adds Ohio practice to network
- Vitana Pediatric & Orthodontic Partners adds New Jersey practice
- Delta Dental of Washington faces class-action lawsuit over reimbursements
- Tennessee Heart converts to independent model
- How this anesthesia residency built its own ASC pipeline
- Hackers threaten to publish 1-800-Dentist files: 5 notes
- California’s school behavioral health reimbursement program stalls
- CMS mulls tougher Medicare enrollment rules to combat fraud as part of 2027 home health payment rule
- The specialties losing private practices fastest
- Tenpoint debuts cast of lively everyday objects to zoom in on blurry vision hassles in Yuvezzi ad
- CMS goes live with GLP-1 Bridge program for Part D beneficiaries
- New Connecticut law expands Yale psychedelic-assisted therapy pilot
- What really breaks physician partnerships?
- The missing piece in crisis care? A model that avoided 1,580 ED days
- Align Technology faces antitrust probe from European Union: 8 things to know
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Lonza expands partnership with US drugmaker, boosts capacity for ADCs
- Trump administration withholds funds from New York's Medicaid fraud unit
- Alcohol accounts for 74% of substance use inpatient stays: 4 things to know
- Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio
- Regulatory tracker: FDA sets decision date for Sarepta's DMD drugs
- Can A Popular Muscle Supplement Help Treat Depression?
- Zelis rolls out AI solution to help payers navigate No Surprises Act dispute process
- BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Kimball lays out $103M to bolster life sciences CDMO footprint across Europe, India
- Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations
- ACCESS Model: behavioral health edition
- Would Hunters Take A Lyme Disease Vaccine? We Asked
- Affordable Healthcare Emerges as a Voter Priority in Purple Nevada
- Newsom Vowed To Transform Kids’ Mental Health. Many California Schools Are Still Waiting.
- Plus Therapeutics rebrands as Cerenome as it deepens AI strategy
- Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next?
- Colorado system transitions behavioral health crisis center to walk-in model
- Columbia, Weill Cornell secure $17.25M for profound autism research
- 16 state behavioral health policy updates
- Kansas bans kratom, 7-OH
- Remarks at the Economic Club of New York
- Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward
- Pediatric cannabis exposures rose 6,000% since 2009: 5 things to know
- 26 states sue CMS over final Medicaid work requirements rule
- Startup Queue lands $12.6M to launch autonomous robotic pharmacy kiosks
- Carbon Health agrees to revise contracts with its California clinics, pay penalties
- Experity acquires Exdion Healthcare to accelerate on-demand care RCM automation
- AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas
- From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply
- A 40-Year-Old Law Requires ERs To Treat Everyone — Unless They Opt Out
- Major Study Supports Same-Day COVID-19 and Flu Vaccination
- American Hospital Association names Steve Walsh as next CEO
- Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort
- Hyro rolls out analytics platform to glean insights from AI agent interactions
- Women With Parkinson's More Likely To Have Brain Changes Related To Alzheimer's
- Even Mild Weather Changes Impact Mental Health
- Breastfeeding Might Lower ADHD Risk, Study Finds
- After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL
- FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program
- She Struggled To Get A Lifesaving Drug Even After Insurers Vowed To Help
- Trouble Getting Weight Loss Drugs Covered By Insurance? Here's What To Know
- He Dreamed of Becoming a Physician Assistant. New Loan Rules May Thwart Him.
- Would Hunters Take a Lyme Disease Vaccine? We Asked
- These Church Members Disagree on Politics. Together They’re Wiping Out Medical Debt.
- Unicycive turned away by FDA again over manufacturer’s plant shortfalls
- Rising Stars: How Novo Nordisk’s Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer
- Rural residents falling behind urban and suburban communities on medical, cancer screenings
- CMI Media Group bridges gaps in pharma marketing tech with newly launched Ad Astra platform
- How payers, drugmakers can collaborate to drive more outcomes-based contracts
- BeOne’s Brukinsa hits goal in mantle cell lymphoma confirmatory trial
- HRSA opens applications for $140M in rural health grant funding
- ACA marketplace enrollment down by 3M as of February, new federal data show
- Cases Of Rare But Dangerous Powassan Tick Virus Rising In U.S.
- Nearly 3 in 10 Young Adults Don't Have a Regular Doctor, Survey Finds
- Clinic network CEO pleads guilty to embezzling millions for 'social media influenced' market trading
- AI playing a major role in consumers' healthcare decision-making, survey finds
- Zymeworks acquires struggling Theravance for $929M
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Klick bags Oxford PharmaGenesis in 3rd takeover in 18 months
- FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster
- Fertility Preservation Often Overlooked In Women's Cancer Care, Review Finds
- Sedatives Pose Fall Hazard For Recently Hospitalized Seniors
- Fourth Of July Poses Burn Hazards — Here's How To Protect Kids
- Efforts To End School Vaccine Mandates Hit A Wall In Florida
- A Dog's Stride Could Be An Early Sign Of Dementia, Study Says
- Florida Hospitals Act Fast To Discharge Gun Victims — Especially if They’re Not Insured
- She Struggled To Get a Lifesaving Drug Even After Insurers Vowed To Help
- Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa
- Doctronic, Simple HealthKit partner to connect at-home screening with AI-powered clinical care
- HHS announces new oversight measures for TEFCA, touts 1B health records exchanged
- Cancer Drug Shortage Renews Calls For Federal Action
- 3 in 10 adults turn to AI or social media for health advice, citing difficulties accessing and affording care
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- Saint Peter’s Healthcare System Expands Intelligent Hospital Room Initiative with hellocare.ai to Advance AI Assisted Patient Safety and Virtual Care
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- One Brooklyn Health Selects hellocare.ai to Advance AI-Powered Virtual Care Across Its Hospitals
- FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- Very Few Men Discuss Prostate Cancer Screening With Their Doctor
- Severe Pregnancy Nausea Tied To Higher Risk Of Complications
- A Ban Won't Stop Abortion Pill Access, Telehealth Providers Say
- UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates
- Even 5-Minute Movement Breaks Can Boost Your Mood And Fight Fatigue
- Belly Laughs Spring From The Primitive Brain, Researchers Say
- Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Real-world data powers next-gen biopharma
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
Michigan healthcare freedom community forum
This month we have dueling op-eds in the Detroit Free Press from Tricia Keith, the new President and CEO of Blue Cross/Blue Shield of Michigan followed by a response from Brian Peters, the CEO of the Michigan Health & Hospital Association.
First, Ms. Keith's opening shot on October 13th:
BCBSM CEO pens op-ed: Health care costs are rising. We need to reform the system.
Opinion by Tricia Keith - October 13, 2025The affordability of health insurance is severely strained right now, with premium increases in the double digits being passed along to many Michiganders for the past several years in a row.
Tackling this affordability crisis isn’t something we can do alone. It requires partnerships — across health systems, providers, insurers, regulators and pharmaceutical companies — to address the root causes of rising costs.
Rising health care costs hurt everyone
Skyrocketing medical and drug costs drove Blue Cross Blue Shield of Michigan’s claims expense higher by $12 million per day in 2024.
According to a recent survey from the Small Business Association of Michigan, the impact of rising premiums is now causing employers to shift more costs to their employees and to reevaluate the richness of their benefit plans, or even whether to provide coverage at all.
In Michigan, a state with such a strong tradition of employer-sponsored health insurance, we need to recognize the factors driving these costs higher and work together on system-wide solutions to keep high-quality health insurance affordable for our members.
It’s important to note that rising upstream costs for medical care, hospital care and new, expensive drugs are not just being felt downstream by health insurers — but also by employers who self-fund their health plans and the members who pay into them.
These employers assume the financial responsibility for paying a significant portion of their employees’ medical and pharmacy costs. Many of the largest Michigan companies fall into this category. The more they spend on health care, the less they spend to hire the workers, invest in the new products, and drive the growth that keeps Michigan’s economy strong.
Value-based payments
At Blue Cross Blue Shield of Michigan, 47 cents of every premium dollar was paid for hospital care in 2024. Insurers and hospital systems must partner more strongly to put more of that money to work paying for patient health — with a growing share of payment tied to the success of hospitals in achieving quality patient outcomes. The solution is leaning into the value-based payment model, and away from the antiquated “fee-for-service” where providers get paid for every test, treatment or procedure they perform — whether it helps the patient during their first visit or not.
Value-based payment models incentivize coordinated care between doctors and health systems and emphasize keeping patients healthy, reducing the need for expensive follow-up treatment.
We can’t just pay hospitals more for the same level of quality and care. We need to pay them to achieve better results.
This approach is at the heart of the multi-year payment contract Blue Cross signed earlier this year with Corewell Health. This five-year deal strives to improve the quality and affordability of patient care through multiple health outcomes-based initiatives.
We also must address — on a national level — the skyrocketing cost of prescription and specialty drugs for complex, chronic conditions and the enormous advantages provided to drug makers in pricing and marketing their expensive, but often life-changing, products.
Rising drug costs
Blue Cross’ claims expense for drugs grew 15% in 2024 — five times the rate of inflation.
The cause? Drug makers can price their products with no regulation, and enjoy patent protections that keep lower-cost competitors out of the market. This is a government-sanctioned monopoly and must be reformed to encourage competition that lowers costs.
For example, Blue Cross is investing in biosimilar drugs to provide lower-cost, effective alternatives to brand name medications. Biosimilars are interchangeable, FDA approved drugs with the same clinical effectiveness as their brand name counterpart. Our switch to a biosimilar for the autoimmune and inflammatory disease drug Humira resulted in saving our customers over 90% of the list price of that medication. We need more competition like this because it lowers costs.
The high cost of advertising
As we all know well, there is also drug advertising. In just the first three months of this year, drug makers spent $729 million on television advertising to drive demand for their high-priced products. In 2024, they spent $5.3 billion on television ads. And it’s all tax-deductible.
Recently, the current administration announced a proposal to rein in TV advertising for prescription drugs. Why does this matter? Direct-to-consumer advertising for prescription drugs increases patient demand, which raises the ability of manufacturers to negotiate higher prices for already expensive drugs. Meaning these higher costs impact individuals and businesses downstream.
The Blue Cross and Blue Shield Association supports a proposal to eliminate the tax deductibility of pharmaceutical advertising, saving $137 billion from 2026-2035. The bottom line is, we need to reform this system that drives drug prices — and health insurance premiums — higher.
These are among many initiatives that Blue Cross supports to help our members, customers and economy better afford health care. Affordability matters. But we need more system-wide solutions to curtail escalating costs and keep health insurance within reach for businesses and people ― and we have to work together to reach them.
Tricia Keith is the new (this year) president and CEO of Blue Cross Blue Shield of Michigan.
Here is Brian Peter's response:
Hospital association head: 'Finger-pointing' won't fix rising health care costs | Opinion
By Brian Peters, Op-ed contributor - October 21, 2025Finger-pointing makes headlines, but it won’t fix Michigan’s health care challenges. Rising costs are real for families and employers — and for hospitals, too. What’s not real is the claim that hospitals are driving those costs with unnecessary or ineffective care. That narrative misunderstands the complexities pushing spending higher, and risks harming patients by undermining the very providers keeping emergency rooms, trauma centers and maternity units open.
Let’s start with what hospitals can’t control.
Drug spending surged in 2024, driven by several high-cost medicines in oncology, diabetes and autoimmune disease, the PwC Health Research Institute found. At the same time, labor — the people who staff intensive care units, operating rooms and emergency departments around the clock — is the single largest expense for hospitals, accounting for more than half of total costs as wages rose to retain nurses and other critical staff during an unprecedented workforce shortage, according to the American Hospital Association.
On top of that, inflation, supply chain disruptions and tariffs continue to push up the price of routine medical supplies, from surgical gowns to IV tubing.
Reimbursements don't cover the cost of care
Hospitals also treat everyone seeking emergency care. In line with our mission and federal law, we care for everyone who comes through our doors, 24/7, regardless of their ability to pay. When a patient arrives with a stroke at 3 a.m. or a child needs trauma care after a car crash, no hospital in Michigan asks for a credit card before providing care. That’s a promise we will always keep.
Meanwhile, public reimbursements routinely fail to cover the cost of that care. In the most recent national data, Medicare paid just about 83 cents for every dollar it costs hospitals to care for a Medicare patient, contributing to more than $130 billion in annual underpayments when Medicare and Medicaid are combined, per the American Hospital Association. Hospitals also deliver tens of billions of dollars in essential but uncompensated care each year to patients with no ability to pay, the association found.
Michigan’s picture mirrors these national pressures. Hospitals across our state continue to absorb more than $1 billion in uncompensated and under-reimbursed care collectively. Rural and northern communities feel these pressures most acutely, where keeping obstetrics or inpatient psychiatric services open can hinge on razor-thin margins, the Michigan Health & Hospital Association, the group I lead, found.
Follow the money
Margins tell the real story.
Michigan was one of only four states in the country where hospitals had, on average, a negative margin, according to the Kaiser Family Foundation. In rural America, closures and conversions have accelerated since 2010, and nearly half of rural hospitals nationally are now in the red, and hundreds vulnerable to closure.
In Michigan, more than half of rural hospitals are operating at negative margins, the Chartis Center for Rural Health reported. These are not signs of a system profiteering off patients. These are signals of a system under financial stress.
And when hospitals are financially destabilized, patients pay the price, not through higher prices but through lost access. When a mother in the U.P. must drive over an hour to deliver a baby, that’s not a finance story. It’s a public safety crisis.
If you want to know who is profiteering off health care, follow the money.
Independent analyses show drug manufacturers’ margins far exceed those of hospitals, with drug company profitability running two to three times higher than hospital margins in many comparisons, according to the Journal of the American Medical Association (JAMA). A 2024 review of sector margins likewise found that PhRMA’s average net income margins dwarf those of other drug-supply-chain players, the Campaign for Sustainable Rx Pricing found.
Hospitals are the backbone of care
Hospitals are doing our part.
Across Michigan, hospitals are moving care to more affordable settings, using lower-cost medication alternatives when appropriate, improving care coordination and expanding the behavioral health workforce.
But no health system can sustain 24/7 readiness — trauma, neonatal intensive care, emergency psychiatry — if reimbursement chronically fails to meet the actual cost of care and costs for labor, supplies and drugs continue to rise.Let’s be honest with patients and employers: Hospitals are not the villains of affordability.
We’re the backbone of access: the nurse at the bedside at 3 a.m., the surgical team on call, the therapist helping a child walk again. Michigan hospital teams will keep showing up with compassion and professionalism.
What we ask in return is an honest conversation grounded in facts, not talking points, because protecting access to care in every Michigan community is a responsibility we all share.
Brian Peters is CEO of the Michigan Health & Hospital Association. It should be noted that Republican House Speaker Matt Hall has called for his ouster, repeatedly, after President Peters and his group criticized the nearly $79 billion Michigan FY 26 budget. President Peters is quite enthusiastic about health care spending.
Stephen Rapundalo, the President and CEO of Ann Arbor-based MichBio, the Michigan Biosciences Industry Association, wants in on the debate:
BCBSM CEO blamed drug industry for rising health care costs. She got it wrong. | Letter
By Stephen Rapundalo - October 23, 2025In a recent ep-ed, Blue Cross and Blue Shield of Michigan CEO Tricia Keith laid out a number of cost drivers in the health care system.
Unfortunately, she didn’t take any responsibility for the role that Blue Cross plays in the increased costs to patients. Instead, she assigned blame to other players in the system, without proposing what health insurers could actually do to help reduce costs.
BCBSM CEO pens op-ed: Health care costs are rising. We need to reform the system.
I lead the Michigan Biosciences Industry Association, or MichBio, an association of research and manufacturer companies that develop life-improving and life-saving medicines for patients in need.Michigan has been on the leading edge of some of the most blockbuster drugs that continue to help people live better and longer lives.
Just two examples include Lipitor, the best-selling cholesterol-lowering drug in history, which was developed in Ann Arbor at Parke-Davis Pharmaceuticals, and AZT, the first approved treatment for HIV/AIDS, discovered at Wayne State University, giving hope to millions across the globe.
The fact is, medical science has never been more promising, and despite all the groundbreaking innovation in medicine, spending on medicines remains a small and stable 14% of total health spending.
I was especially surprised that Keith didn’t mention the role that Pharmacy Benefit Managers (PBMs) play in inflating the costs of prescriptions for patients. They’re the middlemen that set the actual price of medications. Pharmaceutical companies sell their products at much lower costs, but PBMs mark up the price and make billions in profits as a result. Some PBMs are owned by the actual pharmacies, so they’re making huge profits off every step in the health care process.
Instead, Keith proposed eliminating the ability of pharmaceutical companies to advertise their products. The result would be a less informed patient, and lead to insurance company bean counters telling your doctor what they can and cannot prescribe. This would not make health care better; it would make bigger profits for health insurers.
If Keith wants to go down the advertising route, Blue Cross should consider reducing its advertising and sponsorship budget. You can’t attend a sporting event without seeing their logo plastered all over the stadium.
What if they, instead, reduced their costs to patients with those funds? Maybe they wouldn’t have to charge double-digit premium increases every year.
Keith also complains about patent protection for companies that have made major discoveries. Can you imagine investing billions into research and development to come up with a life-saving medicine, you file for a patent and are told it’s only valid for seven years?
In fact, 90% of prescriptions in the U.S. are filled with lower-cost generics and biosimilars.
As a company, you have to cover your investment costs within that timeframe, and then generics manufacturers are allowed to make and sell your product. Seven years is a very short timeline, but without even that minimal protection, who would do the research and testing that’s necessary?
The bottom line is that everyone in the health care ecosystem has a role to play in reducing costs for patients.
So instead of pointing fingers, how about if everyone sits down and figures out what is best for patients?
That may be the optimist in me hoping for that kind of result, but it’s the only way we’re going to do what’s right by the patients that the system is supposed to help.
The Hill brings the bigger picture of public perspective.
Chronic finger-pointing can be entertaining, but have you noticed that for industry it's all about managing people's lives?
What gets really interesting is personal responsibility, medical debt, and individual freedom.
https://thehill.com/policy/healthcare/5572504-healthcare-affordability-voter-poll/
Many voters say health care unaffordable, are open to new insurance system: Poll
Joseph Choi | 10/27/25
New polling has found that the majority of voters say health care in the U.S. is unaffordable and are open to a health insurance system that doesn’t tie coverage to employment.
Undue Medical Debt, a nonprofit that works to eliminate medical debt and supports policies to prevent new debt, sponsored the poll, which was led by the nonpartisan research firm PerryUndem. Along with a national survey, focus groups were also asked for their opinions on health care.
The poll was provided first to The Hill.
The survey found that 69 percent of voters believe that health care is not affordable today, with that figure remaining relatively consistent across parties.
Thirty-five percent of participants said they currently owed money or have debt due to medical or dental expenses. The same percentage said they had skipped or delayed medical care in the last year due to fears of medical debt.
Survey participants were asked whether they made at least one of eight material sacrifices in the past year in order to meet their financial goals. These included eating less food, skipping vacations, putting more of their expenses on credit cards, falling behind on bills and borrowing money from friends and family.
Among those surveyed, 68 percent said they had engaged in at least one of those practices, with 43 percent saying they’d eaten less or bought less expensive, less healthy foods.
One participant, a 43-year-old uninsured white woman in West Virginia, said in the survey, “I go to a food pantry and I work three jobs. You know what I mean? It’s hard, and it shouldn’t be that hard. I don’t have time to spend with my kids. I don’t have time to do things, because I have to work to eat, you know, and that’s what makes it hard for me.”
“This is a common ground issue that you know is resonating with people. Health care is clearly unaffordable,” Allison Sesso, president and CEO of Undue Medical Debt, told The Hill.
“What I thought was really interesting is really the focus on insurance,” Sesso added. “Seventy-four percent saying that insurance is failing to protect them from medical debt. And I think that that, to me, is a little bit new. Not that it’s new that insurance isn’t working that great, but that such a large percentage of voters on both sides of the aisle were pointing that out as one of the biggest failures.”
Sixty-three percent of participants said they blamed insurance companies the most for medical debt, which was very distantly followed by pharmaceutical companies at 12 percent and hospitals at 9 percent.
Seventy-six percent of voters said they agreed with the statement: “We need to switch to a different system of health insurance where people can change jobs or become self-employed and not have to worry about losing their health insurance.”
“They want to see a system that doesn’t tie them so tightly to their jobs, because it prevents them from moving around,” Sesso said. “And, you know, if you’re not sick, you’re sort of punished to stay at the job, and you don’t have the ability to be sort of self-employed, that you have to sort of hold on to that job for the insurance aspect of it
When it came to addressing medical debt, 76 percent said they wanted their states to pass laws shielding them from medical debt. Measures that received significant support included limiting the interest rate allowed on medical debt, limiting the ability of collection agencies to take a person’s belongings due to medical debt and requiring hospitals to use the same user-friendly application for financial assistance.
Eighty-one percent said they supported the creation of a state-funded health plan that would give residents a more affordable option than commercial plans.
Seventy-seven percent of voters said they would feel more positive about state elected officials if they passed laws with these measures and 75 percent said they would be more likely to vote for someone if they passed these laws.
The ongoing discourse over health insurance and ensuring people can afford it is what is currently keeping the federal government shut down. The current shutdown is already the second-longest in U.S. history, and Democrats are refusing to budge unless a deal is struck to extend enhanced premium tax credits for Affordable Care Act Marketplace plans.
“I’m not surprised that health care is at the center of this conversation. Medical debt and healthcare affordability are, you know, among the few issues where Americans actually agree at this moment,” Sesso said. “I think they’re not holding their breath for Washington to act and to protect them necessarily from medical debt, which is why I think they’re, you know, looking for states to take action.”
For the survey, 1,319 voters in the 2024 general election were included in a 12-minute national survey. The survey was conducted from Aug. 21 to Sept. 2. The results have a margin of error of 3.63 percentage points.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















